Clinical Trial Update: Exploratory Study on the S-1 + Paclitaxel Chemotherapy for Unresectable Gastric Cancer [Phase 2]

View source ↗

Summary

An exploratory phase 2 trial evaluating the combination of S-1 and Paclitaxel for unresectable gastric cancer; current status is not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• PACLITAXEL (PACLITAXEL)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Surgically-Created Resection Cavity, Drug Safety | Phase 2 | Status: UNKNOWN